Kang MA et al. |
Up-regulation of skeletal muscle LIM protein 1 gene by 25-hydroxycholesterol may mediate morphological changes of rat aortic smooth muscle cells. |
2007 |
Life Sci. |
pmid:17161435
|
Sánchez-Gómez FJ et al. |
Direct evidence for the covalent modification of glutathione-S-transferase P1-1 by electrophilic prostaglandins: implications for enzyme inactivation and cell survival. |
2007 |
Arch. Biochem. Biophys. |
pmid:17169324
|
Tanaka Y et al. |
Hepatic ischemia-reperfusion induces renal heme oxygenase-1 via NF-E2-related factor 2 in rats and mice. |
2007 |
Mol. Pharmacol. |
pmid:17151289
|
Suwaki N et al. |
Expression and potential role of peroxisome proliferator-activated receptor gamma in the placenta of diabetic pregnancy. |
2007 |
Placenta |
pmid:16753211
|
Da Silva Morais A et al. |
Peroxisome proliferated-activated receptor gamma ligand, Pioglitazone, does not prevent hepatic fibrosis in mice. |
2007 |
Int. J. Mol. Med. |
pmid:17143554
|
Lee JH et al. |
15-deoxy-Delta 12,14-ProstaglandinJ2 regulates dedifferentiation through peroxisome proliferator-activated receptor-gamma-dependent pathway but not COX-2 expression in articular chondrocytes. |
2007 |
J. Korean Med. Sci. |
pmid:17982241
|
Li SJ et al. |
[Effect of peroxisome proliferators-activated receptor gamma ligands on cytotrophoblast invasion in first trimester pregnancy]. |
2007 |
Zhonghua Fu Chan Ke Za Zhi |
pmid:17983488
|
Reyes-Martin P et al. |
Cyclooxygenase-independent inhibition of H2O2-induced cell death by S-ketoprofen in renal cells. |
2007 |
Pharmacol. Res. |
pmid:17291778
|
Gayarre J et al. |
Modification of proteins by cyclopentenone prostaglandins is differentially modulated by GSH in vitro. |
2007 |
Ann. N. Y. Acad. Sci. |
pmid:17405918
|
Li X et al. |
Hypoxia reduces the expression and anti-inflammatory effects of peroxisome proliferator-activated receptor-gamma in human proximal renal tubular cells. |
2007 |
Nephrol. Dial. Transplant. |
pmid:17255125
|
Yang WZ et al. |
[The effect of ligand of peroxisome proliferators-activated receptor gamma 15d-PGJ2 on the proliferation and activation of hepatic stellate cells]. |
2007 |
Zhonghua Gan Zang Bing Za Zhi |
pmid:17362636
|
Kim HJ et al. |
15-deoxy-Delta12,14-prostaglandin J2 inhibits transcriptional activity of estrogen receptor-alpha via covalent modification of DNA-binding domain. |
2007 |
Cancer Res. |
pmid:17363578
|
Fionda C et al. |
15-deoxy-Delta12,14-prostaglandin J2 negatively regulates rankl gene expression in activated T lymphocytes: role of NF-kappaB and early growth response transcription factors. |
2007 |
J. Immunol. |
pmid:17371958
|
Hwang J et al. |
15-deoxy-Delta12,14-prostaglandin J2-induced down-regulation of endothelial nitric oxide synthase in association with HSP70 induction. |
2007 |
Biochem. Biophys. Res. Commun. |
pmid:17418102
|
Fulzele SV et al. |
15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors. |
2007 |
Anticancer Drugs |
pmid:17159504
|
Li SJ et al. |
[Effects of peroxisome proliferator-activated receptor gamma and its ligands on cytotrophoblast invasion in first trimester of pregnancy and mechanism thereof]. |
2007 |
Zhonghua Yi Xue Za Zhi |
pmid:17425848
|
Zhao X et al. |
Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages. |
2007 |
Ann. Neurol. |
pmid:17457822
|
Olmos G et al. |
Accumulation of hypoxia-inducible factor-1alpha through a novel electrophilic, thiol antioxidant-sensitive mechanism. |
2007 |
Cell. Signal. |
pmid:17658243
|
Chintalgattu V et al. |
PPAR-gamma agonists induce the expression of VEGF and its receptors in cultured cardiac myofibroblasts. |
2007 |
Cardiovasc. Res. |
pmid:17320065
|
Fournier T et al. |
Involvement of PPARgamma in human trophoblast invasion. |
2007 |
Placenta |
pmid:17321592
|
Rajakariar R et al. |
Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyDelta12 14 PGJ2. |
2007 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:18077391
|
Mizutani N et al. |
Dose-dependent differential regulation of cytokine secretion from macrophages by fractalkine. |
2007 |
J. Immunol. |
pmid:18025192
|
Kim KY et al. |
Apoptotic action of peroxisome proliferator-activated receptor-gamma activation in human non small-cell lung cancer is mediated via proline oxidase-induced reactive oxygen species formation. |
2007 |
Mol. Pharmacol. |
pmid:17535976
|
Han H et al. |
15-Deoxy-delta 12,14-prostaglandin J2 (15d-PGJ 2) sensitizes human leukemic HL-60 cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through Akt downregulation. |
2007 |
Apoptosis |
pmid:17786557
|
Yoon EK et al. |
ERK-1/-2 and p38 kinase oppositely regulate 15-deoxy-delta(12,14)-prostaglandinJ(2)-Induced PPAR-gamma activation that mediates dedifferentiation but not cyclooxygenase-2 expression in articular chondrocytes. |
2007 |
J. Korean Med. Sci. |
pmid:18162716
|
Brunoldi EM et al. |
Cyclopentenone prostaglandin, 15-deoxy-Delta12,14-PGJ2, is metabolized by HepG2 cells via conjugation with glutathione. |
2007 |
Chem. Res. Toxicol. |
pmid:17854155
|
Wu P et al. |
Inflammation pro-resolving potential of 3,4-dihydroxyacetophenone through 15-deoxy-delta12,14-prostaglandin J2 in murine macrophages. |
2007 |
Int. Immunopharmacol. |
pmid:17761349
|
Richard CL et al. |
15-Deoxy-delta(12,14)-prostaglandin J(2) down-regulates CXCR4 on carcinoma cells through PPARgamma- and NFkappaB-mediated pathways. |
2007 |
Exp. Cell Res. |
pmid:17707368
|
Rollins MD et al. |
Anti-inflammatory effects of PPAR-gamma agonists directly correlate with PPAR-gamma expression during acute pancreatitis. |
2006 Sep-Oct |
J. Gastrointest. Surg. |
pmid:16966031
|
Lappas M et al. |
15-Deoxy-Delta(12,14)-prostaglandin J(2) and troglitazone regulation of the release of phospholipid metabolites, inflammatory cytokines and proteases from human gestational tissues. |
2006 Nov-Dec |
Placenta |
pmid:16434095
|
Berruyer C et al. |
Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activity. |
2006 |
J. Exp. Med. |
pmid:17145956
|
Nakata S et al. |
15-Deoxy-Delta12,14-prostaglandin J(2) induces death receptor 5 expression through mRNA stabilization independently of PPARgamma and potentiates TRAIL-induced apoptosis. |
2006 |
Mol. Cancer Ther. |
pmid:16891469
|
Fu YG et al. |
Inhibition of gastric cancer cells associated angiogenesis by 15d-prostaglandin J2 through the downregulation of angiopoietin-1. |
2006 |
Cancer Lett. |
pmid:16412567
|
Kohno S et al. |
Inhibition of skin sclerosis by 15deoxy delta12,14-prostaglandin J2 and retrovirally transfected prostaglandin D synthase in a mouse model of bleomycin-induced scleroderma. |
2006 |
Biomed. Pharmacother. |
pmid:16337105
|
Xie Y et al. |
Differentiation-dependent regulation of the cyclooxygenase cascade during adipogenesis suggests a complex role for prostaglandins. |
2006 |
Diabetes Obes Metab |
pmid:16367886
|
Landar A et al. |
Induction of the permeability transition and cytochrome c release by 15-deoxy-Delta12,14-prostaglandin J2 in mitochondria. |
2006 |
Biochem. J. |
pmid:16268779
|
Benkirane K et al. |
PPAR-gamma inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1. |
2006 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:16155101
|
Cho WH et al. |
15-deoxy-(Delta12,14)-prostaglandin J2 (15d-PGJ2) induces cell death through caspase-independent mechanism in A172 human glioma cells. |
2006 |
Neurochem. Res. |
pmid:17006759
|
Pereira MP et al. |
Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms. |
2006 |
J. Cereb. Blood Flow Metab. |
pmid:16034372
|
Gayarre J et al. |
Addition of electrophilic lipids to actin alters filament structure. |
2006 |
Biochem. Biophys. Res. Commun. |
pmid:16979589
|
Eucker J et al. |
Peroxisome proliferator-activated receptor-gamma ligands inhibit proliferation and induce apoptosis in mantle cell lymphoma. |
2006 |
Anticancer Drugs |
pmid:16926626
|
Willermain F et al. |
15-Deoxy-12,14-prostaglandin J2 inhibits interferon gamma induced MHC class II but not class I expression on ARPE cells through a PPAR gamma independent mechanism. |
2006 |
Prostaglandins Other Lipid Mediat. |
pmid:16939878
|
Lim HJ et al. |
PPARgamma activation induces CD36 expression and stimulates foam cell like changes in rVSMCs. |
2006 |
Prostaglandins Other Lipid Mediat. |
pmid:16939881
|
Makino N et al. |
Peroxisome proliferator-activated receptor-gamma ligands attenuate brain natriuretic peptide production and affect remodeling in cardiac fibroblasts in reoxygenation after hypoxia. |
2006 |
Cell Biochem. Biophys. |
pmid:16456235
|
Belvisi MG et al. |
Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation. |
2006 |
Eur. J. Pharmacol. |
pmid:16458290
|
Kang HY et al. |
Peroxisome proliferator-activated receptors-gamma activator, ciglitazone, inhibits human melanocyte growth through induction of apoptosis. |
2006 |
Arch. Dermatol. Res. |
pmid:16474974
|
Schröder O et al. |
15-deoxy-Delta12,14-prostaglandin J2 inhibits the expression of microsomal prostaglandin E synthase type 2 in colon cancer cells. |
2006 |
J. Lipid Res. |
pmid:16495511
|
Moulin D et al. |
Effect of peroxisome proliferator activated receptor (PPAR)gamma agonists on prostaglandins cascade in joint cells. |
2006 |
Biorheology |
pmid:16912428
|
Kim EH and Surh YJ |
15-deoxy-Delta12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors. |
2006 |
Biochem. Pharmacol. |
pmid:16987499
|
Qin S et al. |
Protection of RPE cells from oxidative injury by 15-deoxy-delta12,14-prostaglandin J2 by augmenting GSH and activating MAPK. |
2006 |
Invest. Ophthalmol. Vis. Sci. |
pmid:17065531
|